However, this objective must be attained by means which will not hinder the development of the pharmaceutical industry or trade in medicinal products within the Community.
Recital 3, Directive (EU) 2001/83
The 10 that are cited most themselves, of 24.
Judgment of the Court (First Chamber) of 15 November 2007. Commission of the European Communities v Federal Republic of Germany.Decision
The second to the fifth recitals in the preamble to Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (OJ 2001 L 311, p. 67) state: The …
15 Nov 2007 · 62005CJ0319
Judgment of the Court (Fourth Chamber) of 16 March 2023. European Commission and Others v Pharmaceutical Works Polpharma S.A.Decision
By that decision, Tecfidera was authorised as a mono-substance medicinal product, composed of DMF, and indicated for the treatment of multiple sclerosis. The Commission also held that Tecfidera did not belong to the same global marketing …
16 Mar 2023 · 62021CJ0438
Judgment of the Court (Second Chamber), 28 June 2012. Fabio Caronna.Decision
Recitals 2 to 5 and 35 and 36 of the Directive are worded as follows: The essential aim of any rules governing the production, distribution and use of medicinal products must be to safeguard public health. However, this objective must be …
28 Jun 2012 · 62011CJ0007
Judgment of the Court (Second Chamber) of 2 April 2009. Criminal proceedings against Frede Damgaard.Decision
Recitals 2 and 3 in the preamble to Directive 2001/83 state the following: ‘(2) The essential aim of any rules governing the production, distribution and use of medicinal products must be to safeguard public health. (3) However, this …
2 Apr 2009 · 62007CJ0421
Judgment of the Court (Third Chamber) of 11 June 2020. ratiopharm GmbH v Novartis Consumer Health GmbH.Decision
Recitals 2 to 4, 14, 45 to 47, 50 and 51 of Directive 2001/83 are worded as follows: The essential aim of any rules governing the production, distribution and use of medicinal products must be to safeguard public health. However, this …
11 Jun 2020 · 62018CJ0786
Judgment of the Court (Sixth Chamber) of 15 December 2016. LEK Farmacevtska Družba d.d. v Republika Slovenija.Decision
Recitals 2 to 5 of Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (OJ 2001 L 311, p. 67), as amended by Directive 2011/62/EU of the …
15 Dec 2016 · 62015CJ0700
Opinion of Advocate General Trstenjak delivered on 21 June 2007. Commission of the European Communities v Federal Republic of Germany.Decision
Recitals 2 to 5 of Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use state: The essential aim of any rules governing the production, …
21 Jun 2007 · 62005CC0319
Opinion of Advocate General Bot delivered on 12 June 2014. Markus D. and G.Decision
The principles established by the EU legislature concerning the legislation applicable to medicinal products are based on the protection of human health and on the free movement of goods within the European Union. (22)
12 Jun 2014 · 62013CC0358
Opinion of Advocate General Szpunar delivered on 18 December 2025. FARMAKEIO YZ & SIA O.E. v Ypourgos Anaptyxis kai Ependyseon and Ypourgos Decision
Although the recitals of Directive 2001/83 mention a single objective – namely the protection of public health by combating falsified medicinal products – its provisions must be interpreted in context. The aim of that directive, which …
18 Dec 2025 · 62024CC0604
Opinion of Advocate General Wahl delivered on 20 May 2014. Olainfarm AS v Latvijas Republikas Veselības ministrija and Zāļu valsts aģentūra.Decision
It follows from recital 2 in the preamble to Directive 2001/83 that the overarching aim of rules governing the production, distribution and use of medicinal products must be to safeguard public health. However, according to recital 3, this …
20 May 2014 · 62013CC0104